Articles from Red Nucleus

Red Nucleus, a leading, global provider of strategic services and solutions across the life sciences product lifecycle, today announced its inclusion in the 2026 MM+M Agency 100, the annual ranking of the most influential healthcare marketing and communications agencies in North America. Published by MM+M (Medical Marketing + Media), the Agency 100 recognizes organizations that are shaping the future of healthcare communications through innovation, scientific expertise, strategic insight, and measurable client impact.

Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access, commercial, and learning & development, today announced that it has acquired Bridge Medical Consulting, a specialized health economics and outcomes research (HEOR) consultancy. The acquisition represents a key step in Red Nucleus’s strategy, strengthening its ability to help biopharmaceutical companies demonstrate the clinical and economic value of increasingly specialized therapies in a complex regulatory and reimbursement environment and bolstering its current set of capabilities within HEOR.

Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access, commercial solutions, and learning and development, today announced that it has acquired COEUS, a multi-specialty, commercially aligned consultancy offering a comprehensive suite of informed solutions for successful engagement with organized customers, providers, and patients. Established in 2009 and recognized as a leader in market access consulting and communication services, COEUS’ capabilities around payor outreach, engagement, and education will augment Red Nucleus’ industry-leading market access services for the world’s leading life science organizations.

Red Nucleus ( “the Company”), a leading provider of strategic services across research and development, medical affairs, market access, and learning and development, today announced that it has received a majority investment from THL Partners (“THL”), a premier private equity firm investing in middle market growth companies. The strategic partnership will help broaden the Company’s suite of commercialization services for its global customer base.